Ledger.Open graph →
SEC Form D · filed October 2, 2023

NurExone Biologic Inc

Offering
$742K
Sold
$742K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BNEI-BRAK, L3
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Michael K. Mckenna · VANCOUVER, British Columbia, CanadaExec · DirectorScott Taylor · VANCOUVER, British Columbia, CanadaDirectorLior Shaltiel · Bnei-Brak, L3Exec · DirectorAnton F. Klaveness · VANCOUVER, British Columbia, CanadaDirectorChristopher K. Green · VANCOUVER, British Columbia, CanadaDirectorOded 4. Orgil · Bnei-Brak, L3DirectorMichael F. Westlake · VANCOUVER, British Columbia, CanadaExecOded 4. Orgil · Bnei-Brak, L3DirectorEran Ovadya · Bnei-Brak, L3ExecYoram 4. Drucker · Bnei-Brak, L3DirectorGadi Riesenfeld · Bnei-Brak, L3DirectorGadi Riesenfeld · Bnei-Brak, L3DirectorJames 4. Richardson · Bnei-Brak, L3DirectorEran Ovadya · Bnei-Brak, L3ExecLior Shaltiel · Bnei-Brak, L3Exec · DirectorJoseph K. Fuqua · VANCOUVER, British Columbia, CanadaDirectorJames 4. Richardson · Bnei-Brak, L3DirectorYoram 4. Drucker · Bnei-Brak, L3Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗